ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

9 links1 made here, not in the record9 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05406999Neoadjuvant IntenseEndocrine Therapy for HighRisk and Locally AdvancedProstate CancerThe Affiliated Nanjing Drum ToPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSProstatic NeoplasmsNo longer in the registry's filing›As of now · Rule based · Main conditionMain conditionDRUGSAntiandrogensEntry “ADT”, read by our name rule›Nov 18 · Rule based · BackgroundBackgroundAbiraterone AcetateIntervention entry›Nov 18 · Rule based · TestedTestedPrednisoloneEntry “Prednisolone tablets”, read by…›Nov 18 · Rule based · TestedTestedEnzalutamideIntervention entry›Nov 18 · Rule based · TestedTestedApalutamideIntervention entry›Nov 18 · Rule based · TestedTestedRezvilutamideIntervention entry›Nov 18 · Rule based · TestedTestedPARP inhibitorsEntry “PARP inhibitor”, read by our n…›Nov 18 · Rule based · TestedTestedOlaparibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · establishedBackground · established

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Olaparib

Made here1 judgment on this link
NCT05406999gives it, found by reading the recordOlaparibDefined by Claude Opus 5.5Nov 3, 2026, 5:17 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3Olaparibmade hereClaude Opus 5.5Background · establishedCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 18AntiandrogensRule based · role ruleBackgroundCurrent
Nov 18Abiraterone AcetateRule based · role ruleTestedCurrent
Nov 18PrednisoloneRule based · role ruleTestedCurrent
Nov 18EnzalutamideRule based · role ruleTestedCurrent
Nov 18ApalutamideRule based · role ruleTestedCurrent
Nov 18RezvilutamideRule based · role ruleTestedCurrent
Nov 18PARP inhibitorsRule based · role ruleTestedCurrent
As of nowProstatic NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.